Relmada Therapeutics, Inc. Common Stock RLMD
$4.59
+0.22%
at last close
Financials (TTM)
Trailing-twelve-month financial statements are not available for Relmada Therapeutics, Inc. Common Stock (RLMD) — this is common for ETFs and funds, which report holdings rather than income statements. See the overview page for price history and key stats.
Key Stats
- Last Close
- $4.59
- Market Cap
- $488.55 million
- 52-Week Range
- $0.55 – $8.00
- Average Volume
- 1.42 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.